Univision, the leading American Spanish-language media company, withdrew its plans for an initial public offering on Tuesday. The company cited "prevailing market conditions." It originally filed in July 2015 with a proposed deal size of $100 million, likely a placeholder for an IPO that we estimate could have raised $1 billion. Univision also issued a press release stating...read more
As many as three micro-cap companies could have listed on US exchanges in the past week, but none managed to price. They are now scheduled for the week ahead. The long-awaited US election likely deterred offerings, while the Thanksgiving holiday will dampen issuance for the remainder of the...read more
•Another small-cap biotech is set to kick off Q2 pricings
•Timing of the IPO window reopening is still uncertain, but the pipeline remains robust
First IPO of the second quarterAeglea Biotherapeutics (AGLE), which is developing enzymes for rare genetic metabolic diseases and tumors, is planning to price its $60 million IPO...read more
Will good things come to those who wait? In total, we estimate that as much as $7.0 billion that could have been raised in the 4Q15 from high-profile IPOs (mostly large LBOs) has now been pushed back to 2016. This has contributed to 2015 being the ...read more
Univision withdraws IPO that could have raised $1 billion
Univision, the leading American Spanish-language media company, withdrew its plans for an initial public offering on Tuesday. The company cited "prevailing market conditions." It originally filed in July 2015 with a proposed deal size of $100 million, likely a placeholder for an IPO that we estimate could have raised $1 billion. Univision also issued a press release stating...read more
US IPO Weekly Recap: Three micro-cap companies delay IPOs during election week
As many as three micro-cap companies could have listed on US exchanges in the past week, but none managed to price. They are now scheduled for the week ahead. The long-awaited US election likely deterred offerings, while the Thanksgiving holiday will dampen issuance for the remainder of the...read more
Week ahead: Small-cap biotech IPO kicks-off Q2
•Another small-cap biotech is set to kick off Q2 pricings •Timing of the IPO window reopening is still uncertain, but the pipeline remains robust First IPO of the second quarter Aeglea Biotherapeutics (AGLE), which is developing enzymes for rare genetic metabolic diseases and tumors, is planning to price its $60 million IPO...read more
Ten well-known IPOs probably pushed to 2016
Will good things come to those who wait? In total, we estimate that as much as $7.0 billion that could have been raised in the 4Q15 from high-profile IPOs (mostly large LBOs) has now been pushed back to 2016. This has contributed to 2015 being the ...read more